Browse Articles
Discover research articles across all indexed journals
Bridging critical disparities: A telementoring approach to equitable palliative care in Malaysia.
334 Background: Recent evidence shows substantial urban-rural disparities in palliative care access across Malaysia, with pronounced deficits in pain management, end-of-life care, and advance care planning. These gaps are most severe in home and community-based settings where vulnerable populations in rural areas face the greatest barriers to accessing quality care. Addressing this inequity need not depend solely on expanding specialist care. Emerging research demonstrates that generalist healthcare teams can deliver effective palliative care across diverse clinical competencies. Methods: Building on the evidence above, our study goal was to examine the effectiveness of a community palliative care telementoring program that provides continuous, case-based support to primary healthcare professionals in both urban and rural settings. We used a mixed -methods approach, deploying a mid-program survey, focus group discussions, and interviews with participants working in rural and urban areas. Between March and December 2025, more than 500 unique attendees, including doctors, nurses, and other healthcare professionals, participated in 10 virtual telementoring sessions. Results: All 53 program survey respondents (100%) reported implementing evidence-based practices in their clinical settings, with adoption rates exceeding 90% in psychosocial, emotional, and spiritual care needs; communication issues; patients’ physical care needs; assessment of patients and caretaker needs; as well as 70% in care planning and coordination. Qualitative data from interviews and focus group discussions provided deeper insights into best-practice uptake, revealing differential implementation patterns and context-specific challenges encountered by urban and rural healthcare providers. Participants across settings provided concrete examples of practice changes and subsequent patient improvements, demonstrating the program's capacity to translate evidence into action. Conclusions: These findings establish telementoring as a viable, scalable strategy for closing critical gaps in palliative care delivery nationwide, offering a replicable capacity-building model that leverages existing healthcare infrastructure rather than requiring prohibitively costly expansion of specialist services.
Patient preference for large language model (LLM)–optimised oncology trial information: A randomised controlled crossover study.
6 Background: Clinical trial participation in oncology is frequently hindered by complex, jargon-laden information that impairs comprehension by patients and caregivers. LLMs offer a scalable solution to simplify technical text, but their utility in oncology has not been evaluated. Methods: We conducted a randomised, controlled, three-period crossover study at two tertiary breast cancer outpatient clinics in Sydney, Australia. Eligible patients and caregivers evaluated trial descriptions across 3 formats: standard ClinicalTrials.gov text (Control); LLM-optimised text generated using zero-shot prompting with GPT-4 (LLM); and further refined by an oncologist (LLM+E). Latin square randomisation controlled for order effects. The primary endpoint was the Global Preference Score (GPS), operationalised as the minimum Likert rating (1-5 scale) across 5 sections (Title, Summary, Intervention, Description, Eligibility) to reflect that incomprehensibility of any component degrades the overall document utility. Sample size (n≥18) was determined via Monte Carlo simulation to detect a minimum 1 point Likert shift with 90% power (α=0.05); the recruitment target was 36 (accounting for 50% attrition). Primary analysis employed Friedman rank sum test blocked by participant, with a cumulative link mixed model (CLMM) including random intercepts for participants to adjust for age, education, and first language. All LLM generated text (LLM±E) were vetted for accuracy of content by ≥1 medical oncologist. Results: Between September and December 2025, 30 of 31 recruited participants provided crossover responses for primary analysis (401 valid responses across 5 sections, 11% invalid). The mean age was 53 years (95% CI, 44-63), with the majority of respondents being female (n = 27, 90%), native English speakers (n = 24, 80%) and holders of tertiary qualifications (n = 17, 57%); 20 respondents were patients (67%). The median GPS was 3.0 (IQR 2.5) for Control, 4.0 (IQR 2.0) for LLM and 3.0 (IQR 1.5) for LLM+E. LLM achieved a significantly higher GPS vs. Control (p = 0.02, Friedman test). Multivariable CLMM confirmed increased odds of higher preference ratings for LLM text vs. Control (OR 1.83, 95% CI 1.01–3.35, adjusted p = 0.048). Paradoxically, LLM+E showed no improvement over Control (padj = 0.826, r = 0.063). Native English speakers rated contents more critically than non-native speakers (OR 0.092, p = 0.009), independent of arm allocation. Conclusions: LLM optimisation improves patient preference for trial information compared with standard registry descriptors, supporting further evaluation of its use in rendering patient-facing materials. Expert oncologist revision may inadvertently re-introduce complexity, negating the linguistic accessibility gains provided by LLMs, suggesting that human-in-the-loop workflows need caution to preserve linguistic style for accessibility.
Densely Packed and Well-Aligned Liquid-Crystalline Scaffolds Drive Controllable Axial Crystal Strain
Claudin-2 extracellular loop 1-mimetic peptides functionally inhibit combined hepatocellular-cholangiocarcinoma cells
Abstract Combined hepatocellular-cholangiocarcinoma (cHCC-CCA) is a rare and aggressive liver cancer for which effective targeted therapies have not been established. We analyzed claudin expression in cHCC-CCA cell lines (KMCH-1 and KMCH-2) and found that claudin-2 was markedly overexpressed relative to hepatocellular carcinoma and cholangiocarcinoma cell lines, as well as primary hepatocytes. This upregulation was associated with the Wnt/β-catenin signaling pathway, a major regulator of cell proliferation. Claudin-2 knockdown reduced cell viability in both cHCC-CCA cell lines examined, suggesting that claudin-2 supports viability in these cell line models. To test whether claudin-2 function can be modulated extracellularly, we synthesized peptides mimicking the first extracellular loop (ECL1) of claudin-2. Among them, the C-terminal peptide Ex1C selectively reduced the viability of cHCC-CCA cell lines examined, but not that of other cells lacking claudin-2 overexpression. Ex1C suppressed proliferation without inducing cell death and significantly inhibited adhesion of KMCH-2 and KMCH-1 cells to primary hepatocytes. As Ex1C exhibited homotypic self-association, these effects are consistent with interference with ECL1-dependent claudin-2 interactions. Collectively, our findings identify claudin-2 as a characteristic molecular feature of the examined cHCC-CCA cell lines and support the utility of extracellular loop-mimetic peptides as probes to dissect claudin-dependent regulation of proliferation and cell adhesion.
Reply to ‘Stimulating medicines repurposing in the EU: a pilot project’
Microphase Rivet‐Reinforced Interfaces in PTFE Composites: Enabling High Thermal Conductivity and Dimensional Stability for High‐Frequency Substrates
ABSTRACT Heat dissipation remains a formidable challenge for polytetrafluoroethylene (PTFE) based high‐frequency substrates, as the integration of thermally conductive fillers like hexagonal boron nitride (hBN) is often hindered by the intrinsic chemical inertness and ultra‐low surface energy of PTFE. Herein, a soluble fluoroalkyl end‐capped polyimide (FPI) precursor is developed. The amphipathic structure of FPI acts as an intermolecular bridge, facilitating the homogeneous dispersion of hydrophobic hBN within aqueous PTFE emulsions. Upon thermal imidization, in situ microphase “rivet” architectures evolve at the filler‐matrix boundaries, replacing fragile van der Waals contacts with robust, mechanically anchored transitional zones. The topological interlocking significantly restricts the long‐range segmental mobility of PTFE chains, yielding an exceptional thermal conductivity of 2.89 W/m·K (a 7.5‐fold increase) alongside an ultralow copper‐matched coefficient of thermal expansion (12 ppm/K). Remarkably, these breakthroughs are achieved while preserving superior dielectric properties (permittivity D k = 2.52, loss tangent D f = 0.00078 @ 10 GHz). This work establishes a universal and scalable blueprint for fabricating extreme‐performance PTFE substrates tailored for the stringent demands of next‐generation 5G/6G telecommunications.
Fish‐Scale‐Inspired Giant Piezocapacitive Sensors for Human‐Level Touch Perception
ABSTRACT Achieving human‐level touch perception in robotics requires flexible sensors that combine a low detection limit, rapid response, robust reliability, and ease of fabrication. Yet, integrating these diverse characteristics into a single device remains a formidable challenge. This work presents a giant piezocapacitive sensor (GPCS) that matches human touch perception capabilities, based on a fish‐scale‐inspired electric‐field gating film. This mechanically compliant and robust biomimetic film consists of high‐permittivity rigid scales separated by air gaps within an elastomer matrix, resulting in a high bulk permittivity. These gaps act as electric‐field gates that modulate the fringing electric field between electrode pairs, translating subtle mechanical deformations into substantial capacitance changes. Consequently, the GPCS achieves an exceptional bidirectional bending resolution of 0.005° over a range of ± 90° with a response time of 0.6 ms, showing no performance degradation in a 100 000‐cycle bending test. This performance enables the precise discrimination of 16 fabric textures and the detection of surface topographies as fine as 1.8 µm—sufficient to resolve printed toner lines on paper. Finally, a GPCS array is integrated onto a robotic gripper, demonstrating in situ ripeness evaluation of kiwis during grasping, automated fruit sorting, and intuitive human–robot interactions.
Correction: A p.N92K variant of the GTPase RAC3 disrupts cortical neuron migration and axon elongation
Bridging the Gap: Integrating External Beam Radiation Therapy Into the Management of Hepatocellular Carcinoma
Analytical validation of a 90-gene expression assay for pan-cancer tissue-of-origin classification in Southeast Asia.
16 Background: Accurate identification of the tissue of origin (TOO) is critical for enabling site-specific therapy in patients with metastatic cancer, particularly cancer of unknown or uncertain primary (CUP). The 90-gene expression assay (Canhelp-Origin) is an RT-PCR-based RNA assay developed for pan-cancer TOO classification. In a randomized clinical trial (Fudan CUP-001), site-specific treatment guided by this assay significantly improved progression-free survival compared with empirical chemotherapy. To support broader clinical implementation, we performed an analytical validation of the assay using tumor samples from Southeast Asia. Methods: Analytical validation was retrospectively conducted at a central laboratory (M Diagnostics Pte Ltd, Singapore) using total RNA extracted from formalin-fixed, paraffin-embedded (FFPE) tumor specimens collected primarily from Southeast Asian countries. Gene expression of a predefined 90-gene panel was quantified using the QuantStudio 5 real-time PCR platform. A locked 90-gene classifier generated similarity scores (0–100; sum = 100) across 21 candidate tumor types. The analytical performance metrics included classification accuracy, robustness under low RNA input and low tumor cellularity, precision, repeatability, and resistance to variations caused by necrotic tissue, tumor enrichment methods, treatment and metastatic status. Results: A total of 64 tumor samples representing 12 cancer types were evaluated for assay performance. The assay achieved a top-1 accuracy of 84.4% (54/64) and a top-3 accuracy of 93.8% (60/64). Among 20 analytically challenging sample with reduced RNA input and tumor cellularity <60%, the concordance with reference pathological diagnoses was 95.0% (19/20). Precision testing across two operators, two reagent lots, and two PCR platforms demonstrated high reproducibility, with a standard deviation of similarity scores of 1.7 and a coefficient of variation of 2.4%. Repeatability testing showed fully concordant results in duplicate analyses. Accurate TOO classification was maintained in samples containing up to 25% necrotic tissue. Conclusions: The 90-gene expression assay demonstrated robust, precise, and reproducible analytical performance in tumor samples from Southeast Asia. These findings support the assay’s analytical robustness across different populations and its reliability for clinical TOO classification in pan-cancer and CUP settings.
Emotionally expressive facial animation driven by EmotionBERT embeddings
ASO sustains microglial neural repair activity
Spectrum, pathobiology, mechanistic insights and diagnostic challenges of post-CAR T cell therapy lymphoproliferative disorders
Food web complexity underlies biodiversity effects on ecosystem functioning
Electro‐Pyroptosis Immunotherapy of Cancer via Endoplasmic Reticulum‐Mitochondria Crosstalk Evoked by Ultrasound‐Activated Wireless Electrostimulation
ABSTRACT Effectively inducing endoplasmic reticulum (ER) stress to initiate cell pyroptosis is promising to elevate cancer immunotherapy, as it avoids immune escape of tumor cells and insufficient differentiation of immune cells. However, it remains a major challenge due to the lack of effective ways to induce ER stress. Herein, we reported the conceptually new electro‐pyroptosis immunotherapy (EPI‐therapy) of cancer via ER‐mitochondria crosstalk by wireless electrostimulation ( w ES), enabled by ultrasound‐activatable ER‐targeted piezoelectric nanoplatform of FAL&BaTiO 3 @AuNPs that capable of generating a voltage nearly 400 mV for localized w ES to induce ER stress to trigger reactive oxygen species (ROS) generation. The developed EPI‐therapy overperforms the existing drug/chemical‐stimulated ones; it disrupts mitochondrial homeostasis and immunosuppressive microenvironment and activates a long‐term immune memory effect, triggering pyroptosis and immunogenic cell death (ICD) effect to boost the immunogenicity, and hence efficiently inhibit primary tumor growth while resist tumor recrudesce and lung metastasis, promising for future immunotherapy of cancer.
Leaf‐Inspired Eutectic Skin With Extreme Fatigue Resistance and Robust Wet Adhesion for Amphibious Epidermal Electronics
ABSTRACT Reliable skin‐interfacing electronics require soft materials that simultaneously tolerate repeated mechanical deformation and maintain robust adhesion in moist environments. However, conventional hydrogels are inherently limited by water‐induced swelling and interfacial failure. Inspired by the vein‐reinforced architecture of Acorus calamus leaves, we present a fatigue‐resistant and environmentally stable “eutectic skin” composed of an aligned polyurethane fibrous network embedded within a hydrophobic eutectogel matrix. The intrinsic hydrophobicity suppresses hydration to ensure exceptional dimensional stability with less than 1.1% swelling over 100 days. Crucially, the hierarchical fiber reinforcement imparts a unique “soft‐yet‐strong” mechanical behavior. The composite exhibits a tissue‐like softness (Shore A hardness of 13.6 A) yet achieves a true tensile strength of 106.51 MPa and a fatigue fracture threshold of 5.02 × 10 4 J m − 2 (≈3399‐fold enhancement) via strain‐induced crystallization. This exceptional toughness allows the material to sustain 100,000 cycles of notched stretching without crack propagation. The hydrophobic matrix also enables strong wet adhesion to skin (152.2 J m − 2 ). This stable ionic interface supports high‐fidelity electrophysiological signal acquisition during underwater operation and continuous 7‐day monitoring. This work establishes a generalizable strategy for engineering mechanically resilient soft ionotronic interfaces for next‐generation wearable bioelectronics.
Acid-sensing ion channel 2a assembles with epithelial Na+ channel β and γ subunits to form mechanosensitive ion channels
Concurrent Versus Sequential Radiation Dose Escalation to the Surgical Cavity for Conservative Treatment of High-Risk Early Breast Cancer: NRG/RTOG 1005 Phase III Trial
PURPOSE For patients with breast cancer undergoing breast conservation, escalating the dose (boost) of radiation to the lumpectomy cavity after whole-breast irradiation (WBI) reduces ipsilateral breast recurrence (IBR) but extends treatment duration. This phase III trial investigated whether boost delivery during WBI versus after WBI provides noninferior IBR and preserves cosmetic appearance. METHODS NRG/RTOG 1005 randomly assigned patients at higher risk for IBR after lumpectomy and axillary surgery to either a sequential boost of 12 Gy in six fractions(F) or 14 Gy in 7F after WBI of 50 Gy in 25F or 42.7 Gy in 16F (sequential arm) or a concurrent boost of 8 Gy in 15F of 0.53 Gy per day with WBI of 40 Gy in 15F (concurrent arm) using 3-dimensional conformal radiation therapy (RT) or intensity-modulated RT. Based on 1.59% 5-year IBR for the sequential arm, defining the noninferiority margin as a hazard ratio upper limit on the 90% CI of 2.12, 2,312 patients provide 80% power for noninferiority of IBR as first recurrence for the concurrent arm. Secondary end points included disease-free survival and overall survival, adverse events (AEs), and cosmetic outcomes. RESULTS Between May 24, 2011, and June 20, 2014, 2,354 patients were randomly assigned, with 2,255 eligible for analysis (sequential arm, n = 1,118; concurrent arm, n = 1,137). With median follow-up of 7.3 years, there were 56 IBR events; 5- and 7-year IBR were 2.1% and 2.2% on the sequential arm and 1.9% and 2.6% on the concurrent arm, respectively. The noninferiority criterion was met: HR (90% CI): 1.31 (0.84 to 2.04), P = .037. No differences were observed in AEs, cosmetic outcomes, or survival between arms. CONCLUSION Concurrent boost during WBI results in noninferior IBR compared with sequential boost without worsening toxicity or cosmetic outcomes and reduces overall treatment time.
Mechanistically guided therapeutic strategy for BAP1 mutant tumors through protein stability and chromatin modulation.
307 Background: Mutations in BAP1 occur across multiple cancers and are associated with aggressive clinical phenotypes and limited therapeutic options. Although BAP1 functions as a deubiquitinase, its role in DNA damage responses and potential therapeutic vulnerabilities remains incompletely studied. We examined how BAP1 mutations affect DNA repair and explored rational combination strategies to target these vulnerabilities. Methods: Quantitative proteomics and ubiquitin profiling identified proteins whose stability is regulated by BAP1. A targeted small molecule screen was performed to discover compounds that selectively reduced survival of BAP1 mutant cells. Selected compounds were evaluated using proliferation, viability and apoptosis assays, DNA repair functional assays, and chromatin structure analyses. Drug synergy was determined using combination index modeling. Preclinical efficacy was assessed in cell-derived and patient-derived xenograft models. Results: BAP1 mutations disrupted the stability of key DNA damage response proteins, impairing damage repair efficiency. Treatment with a selected drug combination led to changes in chromatin structure, further reduced DNA repair capacity, and selectively triggered apoptosis in BAP1 mutant cells. The combination treated induced enhanced cytotoxicity, significantly reduced tumor growth, and improved survival in vivo. These effects were specific to BAP1 mutant models and were not observed in BAP1 wildtype tumors. Conclusions: BAP1 modulates DNA repair through effects on protein stability and chromatin dynamics. Our study identifies a mechanistically guided drug combination that selectively targets BAP1-deficient tumors, providing a foundation for further preclinical and clinical evaluation.